SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
Filing Date
May 12, 2014
Document Date
Mar 31, 2014
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.